Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$297,008,878
+$74,475,126 QoQ
Shares Held
247,625
+2.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#217
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $679,497,428 across 14 Drug Manufacturers - General names. LLY ranks #1 (43.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
247,625 | $297,008,878 | |
| 2 | ABBV |
AbbVie Inc.
|
474,171 | $119,320,390 | |
| 3 | JNJ |
Johnson & Johnson
|
393,933 | $100,047,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
370,246 | $47,576,611 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
203,044 | $25,652,578 | |
| 6 | PFE |
Pfizer Inc
|
1,059,033 | $25,501,514 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
384,190 | $22,137,027 | |
| 8 | NVS |
Novartis AG
|
89,153 | $13,972,058 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,008,878 | 247,625 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $222,533,752 | 241,945 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $262,365,951 | 244,134 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $177,755,347 | 232,969 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $182,877,738 | 234,600 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $192,411,426 | 232,969 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $181,880,884 | 235,597 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $218,849,328 | 247,025 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $205,135,568 | 226,574 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||